Fermenta Biotech Key Ratios
NSE: FERMENTA | BSE: 506414
₹514.10
As on 28-Aug-2026 11:44IST
Market cap
₹1,513 Cr
Revenue (TTM)
₹511 Cr
P/E Ratio
25
P/B Ratio
3.7
Div. Yield
0.7 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.20 | -10.60 | -3.15 | 14.49 | 5.42 |
| EBIT | -13.67 | -42.66 | -39.49 | 169.83 | 1.73 |
| Net Profit | -22.38 | -55.40 | -46.96 | 133.62 | 5.11 |
| EPS | -49.27 | -54.64 | -41.53 | 48.73 | 6.96 |
| Book Value | -- | -- | 13.14 | 10.33 | 3.07 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 11.47 | 8.15 | 13.42 | 15.08 | 18.38 |
| Net Margin
| 7.26 | 2.13 | 11.00 | 12.82 | 15.87 |
| Return on equity
| 11.33 | 4.43 | 13.91 | 18.36 | 23.93 |
| Return on Capital
| 15.18 | 9.56 | -- | 21.99 | 21.97 |
| Return on Assets
| 6.65 | 2.88 | 9.22 | 11.13 | 12.85 |
| Debt to Equity (x)
| -- | -- | 0.02 | 0.27 | 0.30 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
21.99
|
21.97
|
1.58
|
-5.25
|
|
Peer Median
|
--
|
19.34
|
21.76
|
21.89
|
--
|
ROE
13.91
Lower than Peers by 1.44
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
13.91
|
18.36
|
23.93
|
-8.30
|
-16.11
|
|
Peer Median
|
15.35
|
16.97
|
17.93
|
16.42
|
--
|
ROA
9.22
Lower than Peers by 1.13
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
9.22
|
11.13
|
12.85
|
-4.01
|
-7.63
|
|
Peer Median
|
10.35
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
13.42
Lower than Peers by 4.58
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
13.42
|
15.08
|
18.38
|
0.94
|
-2.87
|
|
Peer Median
|
18.01
|
18.96
|
18.93
|
21.05
|
--
|
Net Margin
11.00
Lower than Peers by 3.45
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
11.00
|
12.82
|
15.87
|
-6.91
|
-14.82
|
|
Peer Median
|
14.45
|
13.29
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
17.50
|
21.43
|
0.21
|
-7.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-3.15
Lower than Peers by 15.10
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-3.15
|
11.92
|
39.87
|
-4.08
|
-12.19
|
|
Peer Median
|
11.95
|
12.97
|
10.90
|
13.44
|
--
|
EBIT Growth
-39.49
Lower than Peers by 61.08
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-39.49
|
-8.14
|
2,621.42
|
131.54
|
-127.41
|
|
Peer Median
|
21.60
|
15.05
|
15.01
|
23.50
|
--
|
Net Profit Growth
-46.96
Lower than Peers by 69.69
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-46.96
|
-8.05
|
418.23
|
54.81
|
-452.79
|
|
Peer Median
|
22.73
|
11.89
|
14.80
|
30.12
|
--
|
EPS Growth
-41.53
Lower than Peers by 61.56
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-41.53
|
-5.01
|
429.95
|
54.88
|
-430.53
|
|
Peer Median
|
20.03
|
12.16
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
11.21
|
31.23
|
-8.59
|
-15.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.02
Higher than Peers by 0.02
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.02
|
0.27
|
0.30
|
0.48
|
0.72
|
|
Peer Median
|
0.00
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
0.23
|
0.22
|
0.23
|
0.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.86
Lower than Peers by 0.22
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1.86
|
1.86
|
1.50
|
1.35
|
1.19
|
|
Peer Median
|
2.08
|
1.93
|
1.90
|
2.23
|
--
|
Quick Ratio
1.13
Lower than Peers by 0.41
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1.13
|
1.13
|
1.00
|
0.90
|
0.63
|
|
Peer Median
|
1.54
|
1.52
|
1.46
|
1.59
|
--
|
Interest Coverage
8.52
Lower than Peers by 10.86
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
8.52
|
8.57
|
6.59
|
0.43
|
-1.40
|
|
Peer Median
|
19.38
|
19.95
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
21.84
Higher than Peers by 0.46
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
21.84
|
21.24
|
20.28
|
20.80
|
11.90
|
|
Peer Median
|
21.38
|
19.87
|
21.77
|
20.10
|
--
|
Asset Turnover
0.81
Higher than Peers by 0.09
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.81
|
0.83
|
0.79
|
0.56
|
0.50
|
|
Peer Median
|
0.72
|
0.77
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
71.83
|
64.16
|
60.61
|
67.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
95.93
|
82.04
|
118.27
|
151.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
147.04
|
164.01
|
155.24
|
131.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
20.73
|
-17.81
|
23.64
|
87.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
25.01
Lower than Peers by 9.02
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
25.01
|
12.75
|
10.38
|
--
|
--
|
|
Peer Median
|
34.03
|
34.29
|
26.81
|
39.85
|
--
|
Price / Book Value
3.66
Lower than Peers by 1.16
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
3.66
|
2.27
|
2.20
|
1.58
|
1.02
|
|
Peer Median
|
4.82
|
5.12
|
4.65
|
6.11
|
--
|
Dividend Yield
0.73
Higher than Peers by 0.23
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.73
|
1.18
|
0.91
|
0.83
|
1.17
|
|
Peer Median
|
0.51
|
0.51
|
0.61
|
0.37
|
--
|
EV/EBITDA
14.68
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
14.68
|
7.96
|
6.83
|
12.84
|
17.44
|
|
Peer Median
|
--
|
30.60
|
27.02
|
34.57
|
--
|
Market Cap
1,513
Lower than Peers by 17,811
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1,513
|
915
|
798
|
437
|
309
|
|
Peer Median
|
19,323
|
17,990
|
20,914
|
25,297
|
--
|